BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16797343)

  • 1. Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation.
    Lubitz SA; Baran DA; Alwarshetty MM; Zucker MJ; Arroyo LH; Chan M; Courtney MC; Correa R; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2006 Jun; 38(5):1501-6. PubMed ID: 16797343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation.
    Lubitz SA; Pinney S; Wisnivesky JP; Gass A; Baran DA
    J Heart Lung Transplant; 2007 Mar; 26(3):264-72. PubMed ID: 17346629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late steroid withdrawal and cardiovascular events in kidney transplant recipients.
    Arnol M; de Mattos AM; Chung JS; Prather JC; Mittalhenkle A; Norman DJ
    Transplantation; 2008 Dec; 86(12):1844-8. PubMed ID: 19104432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.
    Welten GM; Chonchol M; Hoeks SE; Schouten O; Dunkelgrün M; van Gestel YR; Goei D; Bax JJ; van Domburg RT; Poldermans D
    Am Heart J; 2007 Nov; 154(5):954-61. PubMed ID: 17967603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice.
    Grigioni F; Carigi S; Potena L; Fabbri F; Russo A; Musuraca AC; Coccolo F; Magnani G; Ortolani P; Leone O; Arpesella G; Magelli C; Branzi A
    Transplant Proc; 2006 Jun; 38(5):1507-10. PubMed ID: 16797344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of heart rate as an independent predictor for survival after heart transplantation.
    Anand RG; Reddy MT; Yau CL; Myers L; Amin RR; Stahls PF; Dumas D; Frohlich ED; Ventura HO
    Am J Cardiol; 2009 May; 103(9):1290-4. PubMed ID: 19406274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaanalysis of statins and survival in de novo cardiac transplantation.
    Mehra MR; Raval NY
    Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
    Wu AH; Ballantyne CM; Short BC; Torre-Amione G; Young JB; Ventura HO; Eisen HJ; Radovancevic B; Rayburn BK; Lake KD; Yancy CW; Taylor DO; Mehra MR; Kubo SH; Fishbein DP; Zhao XQ; O'Brien KD
    Am J Cardiol; 2005 Feb; 95(3):367-72. PubMed ID: 15670546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and the risk of cancer after heart transplantation.
    Fröhlich GM; Rufibach K; Enseleit F; Wolfrum M; von Babo M; Frank M; Berli R; Hermann M; Holzmeister J; Wilhelm M; Falk V; Noll G; Lüscher TF; Ruschitzka F
    Circulation; 2012 Jul; 126(4):440-7. PubMed ID: 22761452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
    Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.